Hemolytic uremic syndrome (HUS) in infants is mainly caused by the Shiga toxin (Stx), which is produced by pathogenic Escherichia coli O157:H7. Infants are prone to develop HUS in comparison to older children and adults, but its underlying mechanism remains unknown. Recent observations suggest that reactive oxygen species (ROS) and reactive nitrogen species (RNS) including nitric oxide (NO) may be involved in the pathogenesis of HUS. We therefore measured NO production by neutrophils prepared from infants (6-27 months old), children (5.3-11 years old) or adults (25-47 years old). The NO production was measured by a flow cytometric analysis with a fluorescent indicator (expressed as mean fluorescence intensity), and mRNA expression of inducible NO synthase (iNOS) was analyzed by reverse transcriptionpolymerase chain reaction (RT-PCR). The amount of NO produced was significantly lower in Stx-stimulated neutrophils prepared from infants (45.8 ± 23.3) than that in those from children (120.5 ± 81.5) or adults (127.7 ± 45.8) (n = 10 each group, P < 0.05). The expression level of iNOS mRNA was lower in Stx-stimulated neutrophils of the infants than the level in those of children or adults. In conclusion, Stx increased NO production in neutrophils probably via iNOS. Importantly, the degree of the Stx-mediated increase in NO production was lower in neutrophils of infants compared to those of children or adults, which may explain the higher incidence of HUS in infants. These results suggest that NO may contribute to the cellular defense mechanisms against Stx.
Hemolytic uremic syndrome (HUS) is defined by the simultaneous occurrence of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal injury (Noris and Remuzzi 2005) . HUS occurs in about 3 to 4% of patients suffering from enterohemorrhagic Escherichia coli O-157: H7 (O-157) infection (Akashi et al. 1994; Bell et al. 1994) . About 90% of HUS cases in infants are due to O-157 infections that generate Shiga toxin (Stx). Seventy percent or more of the patients with HUS are children under 15 years of age and those ranging from 0 to 4 years of age account for close to half. Furthermore, the incidence of HUS due to O-157 infections in infants is about 7 times higher than that of adults (Kamioka et al. 2008) , although its precise reason is unknown.
It has been reported that reactive oxygen species (ROS) have an antibacterial action (Cohen 1994 ) and contribute to the development of HUS (King et al. 1999; Liu et al. 2002; Gomez et al. 2005; Holle et al. 2005) . However, the role of nitric oxide (NO), another pivotal biological reactive species generated by vascular endothelial cells or white blood cells, has not been extensively studied.
NO has cytoprotective effects (Elrod et al. 2008 ) and plays some role in the pathophysiology in HUS (Dran et al. 2002) ; namely, administration of arginine, a NO synthesis promoting substance, to the HUS model mice generated with Stx reduced their mortality. Therefore, NO may be involved in the pathophysiology of HUS. However, no studies on NO generated from neutrophils have been reported.
In the current study, we hypothesized that NO plays an important role in the cellular defense mechanisms in HUS caused by Stx from O-157, and thus measured the NO productivity of neutrophils stimulated with Stx-1 to explore the reason for the higher incidence of HUS in infants.
Materials and Methods

Study population
Healthy volunteers (institutional staffs and staffs' children) were enrolled into this study. They were classified into three groups according to their ages: Adults, ten healthy adults (25-47 years of age, median 34.3 years of age); Infants, ten healthy infants (6-27 months of age, median 9 months of age); and Children, ten healthy children (5.3 -11 years of age, median 7 years of age). No subjects had taken oral medicine at the time of blood sampling. The written informed consent for this study was obtained from the adult volunteers and the parents of children in accordance with ethics regulation of Kansai Medical University.
Blood sampling
One ml of blood was drawn via venipuncture and collected with an anti-coagulant (sodium heparin). For measurement of NO produced by neutrophils, 100 µl of whole-blood was transferred into a sterile 6-ml centrifuge tube within 24 hours after sampling.
Measurement of amount of NO production by neutrophils stimulated with Stx
A whole blood sample (100 µl) was transferred to a sterile 6-ml centrifuge tube, and Stx-1 (partially purified at least 10 7 Verocytotoxic units/mg; Toxin Technology, Inc., USA) was added to a final concentration of 0.5 µg/ml. The possibility of the contamination of Stx-1 with lipopolysaccharide (LPS) was low. Each sample was incubated for 90 min at 37°C after addition of 4,5-diaminofluorescein-FM diacetate (DAF-FM DA; Daiichi Pure Chemical Co., LTD, Tokyo, Japan) to a final concentration of 10 µM, and 1,000 µl of 3 mM EDTA (Wako Pure Chemical Industries, Ltd, Osaka, Japan) in phosphate buffered saline (PBS: Takara Shuzo Co. Shiga, Japan) was added. Erythrocytes were hypotonically lysed for 30 sec. The mixture was centrifuged, and each cell pellet was resuspended in 500 µl of 3 mM EDTA in PBS and was applied to flowcytometry. Twocolors fluorescence staining was analyzed by a cytofluorometer (Epics ® XL II, Coulter Co., Hialeah, Florida, USA) with System II Software. Data from 10,000 events per sample were acquired. Excitation and emission maxima of DAF-FM DA were 495 and 515 nm, respectively. The mean fluorescence intensity (MFI) was determined after gating for neutrophils by their forward and side scatter characteristics.
Reverse transcription-polymerase chain reaction (RT-PCR) to examine mRNA expression of inducible NO synthase (iNOS)
A whole blood sample (100 µl) was transferred to a sterile 6-ml centrifuge tube, and Stx-1 was added to a final concentration of 0.5 µg/ml. Each blood sample was incubated with Stx-1 for 90 min at 37°C. Human neutrophils were isolated from whole blood collected from healthy volunteers using the dextran-Ficoll techniques described previously (Wu et al. 2001) . Isolated neutrophils were resuspended in PBS. Total RNA was prepared from the purified neutrophils (1 × 10 6 cells/ml) with an RN easy mini Kit (QIAGEN, Germany) according to the manufacturer's instructions. cDNA was synthesized with a cDNA Cycle kit (Invitogen, USA) using random hexamers. PCR was performed in a final volume of 10 µl containing 1×Gene Taq Universal Buffer, 100 µM dNTP mixture, 0.5 µM gene-specific primers (Table 1) . A solution containing 1.5 units Gene Taq DNA polymerase (Nippon Gene, Japan) was added and cDNA was diluted appropriately. Thirty cycles of PCR were carried at 94°C for 30 sec, at 60°C, for 30 sec, at 72°C for 1 min, and at 72°C for 5 min as a final extension step, respectively. Glyceraldehyde-3-phosphate dehydrogenase (GADPH) was used as control primers. The PCR products were analyzed on 2% agarose gels and visualized with ethidium bromide staining under ultraviolet transillumination.
Statistical analysis
All numerical data are expressed as the median (range) or mean with standard deviation. Statistical significance was determined using the nonparametric Kruskal Wallis test for three samples. P value less than 0.05 was considered to be significant.
Results
Amount of NO produced by neutrophils stimulated with Shiga-toxin
There was no significant difference in the amounts of NO production from neutrophils among adults, infants and children without Stx-1 (Fig. 1) . The amount of NO produced by neutrophils stimulated with Stx-1 was significantly lower in infants (45.8 ± 23.3: ranges, 17.2-88.1 MFI) than in adults (127.7 ± 45.8: ranges, 19.9-172.4 MFI) and children (120.5 ± 81.5: ranges, 40.4-259.2 MFI) (P < 0.05, Fig. 2 ). In contrast, there was no significant difference in the amounts of NO produced by neutrophils between adults and children (Fig. 2) .
RT-PCR analysis for expression of iNOS mRNA
The expression of iNOS mRNA in neutrophils was analyzed by RT-PCR (Fig. 3a) . The RT-PCR analysis of GAPDH mRNA was performed as an internal control. Although the expression of iNOS mRNA was detected in neutrophils after stimulation with Stx-1 in all three groups, its amount was significant lower in infants than in adults and children (P < 0.05, Fig. 3b ). In addition, RT-PCR was performed using a primer set for neuronal NOS or endothelial NOS, but neither mRNA was detected (data not shown).
Discussion
Though several studies have addressed neutrophil ROS production after stimulation by Stx (King et al. 1999; Liu et al. 2002; Fernandez et al. 2005; Gomez et al. 2005; Holle et al. 2005) , none has focused on cellular NO production under Stx stimulation. The pathophysiological role of NO has been extensively studied in hypotension associated with septic shock, i.e., excessive production of NO lowers the blood pressure (Fernandes and Assreuy 2008) . In addition, cytoprotective effects of NO have been recently postulated (Dran et al. 2002) . The current study hypothesized that the suppressed neutrophil NO production is associated with the defective defense mechanisms against Stx leading to HUS, because NO is generated from not only vascular endothelial cells but also circulating neutrophils (Wright et al. 1989; Evans et al. 1996) . This study demonstrated that the amount of NO synthesized by iNOS of neutrophils stimulated by Stx-1 was significantly lower in infants in comparison to older children and adults. This finding might partly explain the higher incidence of HUS induced by Stx-1 in infants with O-157 infection. Prior to the present study, we also analyzed the effect of Stx-2 on the production of NO from neutrophils. However, there was no significant difference in the amounts of NO production between Stx-1 and Stx-2 (data not shown).
LPS contamination in the Stx-1 cannot be ruled out, although we used partially purified Stx-1 in the present study. In this connection, our previous study (Tsuji et al. 2002) showed that the amount of neutrophil NO produced with lipopolysaccharide was increased by about 1.3 times in comparison to non-stimulation. On the other hand, the amount of neutrophil NO was increased about 8 times upon Stx-1 stimulation. It is therefore conceivable that the contribution of lipopolysaccharide contamination may be negligible.
The current study together with the previous reports (Dran et al. 2002; Elrod et al. 2008 ) suggests a cellular defense mechanism against Stx in O-157 infection (Fig. 4) . Stx released from O-157 binds to an unknown receptor different from globotriaosyl ceramide (Gb3/CD77), which is the known of receptor of Stx (Griener et al. 2007 ). The binding of Stx to the receptor leads to the increase in the synthesis of iNOS, which then increases the neutrophil NO production. On the other hand, ROS is also generated by the nicotinamide adenine dinucleotide phosphate oxidase, which is present on the surface membrane of a neutrophil. The generated ROS reacts with NO to produce peroxynitrite (ONOO − ), which has a potent antibacterial action. Both NO and ONOO − exhibit cytoprotective effects and anti-bacterial activity, respectively. Thus, the suppressed neutrophil NO production in infants causes defective immune responses against Stx, resulting in its augmented toxicity leading to HUS.
However, there are several limitations associated with the current study. First, ROS were not measured under the experimental conditions. ROS production should be evaluated in combination with NO to verify the hypothesis, although numerous studies have already confirmed increased production of ROS in HUS (King et al. 1999; Liu et al. 2002; Gomez et al. 2005; Holle et al. 2005) . Secondly, patients with HUS caused by Stx were not included. Comparison of NO production between infants with O-157 infection complicated by HUS and those uncomplicated by HUS is worthwhile to determine the role of NO in its pathophysiology.
In conclusion, the Stx released from O-157 stimulated the neutrophil NO production probably via iNOS, and the degree of this increase was lower in neutrophils of infants compared to those of children or adults. These results suggest that NO plays a role in the cellular defense mechanisms against Stx and may explain the higher incidence of HUS in infants, although further study is clearly needed. [1] Stx-1 combines with an unknown receptor different from globotriaosyl ceramide (the receptor of Stx), [2] thereby promoting synthesis of iNOS and increasing the NO production by the neutrophils.
[3] Superoxide is also generated from the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase present on the neutrophil surface membrane, and [4] the generated superoxide reacts with NO to become peroxynitrite (ONOO − ). NO and peroxynitrite generated in this manner exhibit cytoprotection and anti-bacterial actions.
